1. Home
  2. CLSD vs VRA Comparison

CLSD vs VRA Comparison

Compare CLSD & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • VRA
  • Stock Information
  • Founded
  • CLSD 2011
  • VRA 1982
  • Country
  • CLSD United States
  • VRA United States
  • Employees
  • CLSD N/A
  • VRA N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • VRA Apparel
  • Sector
  • CLSD Health Care
  • VRA Consumer Discretionary
  • Exchange
  • CLSD Nasdaq
  • VRA Nasdaq
  • Market Cap
  • CLSD 68.4M
  • VRA 61.7M
  • IPO Year
  • CLSD 2016
  • VRA 2010
  • Fundamental
  • Price
  • CLSD $0.42
  • VRA $1.96
  • Analyst Decision
  • CLSD Hold
  • VRA Strong Buy
  • Analyst Count
  • CLSD 4
  • VRA 2
  • Target Price
  • CLSD $4.33
  • VRA $4.00
  • AVG Volume (30 Days)
  • CLSD 12.9M
  • VRA 173.1K
  • Earning Date
  • CLSD 08-08-2025
  • VRA 09-10-2025
  • Dividend Yield
  • CLSD N/A
  • VRA N/A
  • EPS Growth
  • CLSD N/A
  • VRA N/A
  • EPS
  • CLSD N/A
  • VRA N/A
  • Revenue
  • CLSD $4,166,000.00
  • VRA $355,671,000.00
  • Revenue This Year
  • CLSD $78.37
  • VRA N/A
  • Revenue Next Year
  • CLSD $17.79
  • VRA $3.80
  • P/E Ratio
  • CLSD N/A
  • VRA N/A
  • Revenue Growth
  • CLSD N/A
  • VRA N/A
  • 52 Week Low
  • CLSD $0.29
  • VRA $1.71
  • 52 Week High
  • CLSD $1.65
  • VRA $6.38
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 39.95
  • VRA 44.51
  • Support Level
  • CLSD $0.40
  • VRA $1.89
  • Resistance Level
  • CLSD $0.47
  • VRA $2.09
  • Average True Range (ATR)
  • CLSD 0.06
  • VRA 0.12
  • MACD
  • CLSD 0.01
  • VRA -0.00
  • Stochastic Oscillator
  • CLSD 26.87
  • VRA 26.00

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

Share on Social Networks: